Cargando…
Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization
The folate receptor alpha (FR) is expressed in a variety of gynecological cancer types. It has been widely used for tumor targeting with folic acid conjugates of diagnostic and therapeutic probes. The cervical KB tumor cells have evolved as the standard model for preclinical investigations of folate...
Autores principales: | Siwowska, Klaudia, Schmid, Raffaella M., Cohrs, Susan, Schibli, Roger, Müller, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620616/ https://www.ncbi.nlm.nih.gov/pubmed/28809784 http://dx.doi.org/10.3390/ph10030072 |
Ejemplares similares
-
Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates
por: Müller, Cristina, et al.
Publicado: (2018) -
Promising potential of [(177)Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model
por: Guzik, Patrycja, et al.
Publicado: (2020) -
Prospects in Folate Receptor-Targeted Radionuclide Therapy
por: Müller, Cristina, et al.
Publicado: (2013) -
(18)F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease—A Proof-of-Concept Study
por: Schniering, Janine, et al.
Publicado: (2019) -
A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice
por: Pellegrini, Giovanni, et al.
Publicado: (2017)